Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Susan E. Siegel currently holds 16,535 shares of NEVRO CORP (NVRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Susan E. Siegel has been a net seller of NVRO stock. They have purchased $0 and sold $775.9K worth of shares.
Susan E. Siegel's most recent insider trade was on May 21, 2026, when they sold 2,072 shares at $144.83 per share.
Susan E. Siegel serves as Executive at NEVRO CORP (NVRO). They have executed 35 insider transactions totaling $775.9K over their tenure at the company.
Susan E. Siegel holds the position of Executive at NEVRO CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Susan E. Siegel has shown a selling trading pattern, with $0 in total purchases and $775.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Susan E. Siegel was on Feb 12, 2020, when they sold $302.5K worth of ALGN shares. This transaction involved 1,100 shares at $275.00 per share.
Susan E. Siegel currently owns 16,535 shares of NEVRO CORP (NVRO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Susan E. Siegel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Susan E. Siegel has 35 Form 4 filings on record as an insider at NEVRO CORP.
Set alerts for Susan E. Siegel and 40,000+ other insiders.